サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
表紙：小児成長ホルモン欠乏症の世界市場調査レポート：産業分析、規模、シェア、成長、動向、2023～2030年の予測
市場調査レポート
商品コード
1342774

小児成長ホルモン欠乏症の世界市場調査レポート：産業分析、規模、シェア、成長、動向、2023～2030年の予測

Global Pediatric Growth Hormone Deficiency Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2023 to 2030

出版日
ページ情報
英文 222 Pages
納期
即日から翌営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=146.99円
小児成長ホルモン欠乏症の世界市場調査レポート：産業分析、規模、シェア、成長、動向、2023～2030年の予測
出版日: 2023年08月01日
発行: Value Market Research
ページ情報: 英文 222 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

小児成長ホルモン欠乏症は、主に小児が罹患する珍しい疾患です。下垂体から分泌される小児成長ホルモンは、小児の成長に不可欠です。生涯を通じて、成長ホルモンは代謝および生理学的プロセスにおいて重要な役割を果たします。下垂体または視床下部が損傷を受けると、生成される成長ホルモンの量が減少し、小児成長ホルモン欠乏症となり、その結果、患児の成長ペースが遅くなり、身長が低下します。

市場力学：

下垂体腫瘍、内分泌疾患、遺伝性疾患、家族関連成長ホルモン欠乏症の有病率の上昇は、小児成長ホルモン欠乏症市場を拡大させる可能性が高いです。医学の進歩、政府補助金の増加、この問題に対する認識を高めるための複数の組織による活動の高まりが、小児成長ホルモン欠乏症市場を前進させる要因です。また、小児診断プロジェクトやキャンペーンが増加していることも、小児成長ホルモン欠乏症市場を拡大させるでしょう。しかし、小児成長ホルモン欠乏症注射の高額な費用、ホルモン治療に関連する副作用、成長ホルモン欠乏症に対する不十分な認識が、小児成長ホルモン欠乏症市場の成長を妨げる主な要因であると予測されています。

調査レポートは、ポーターのファイブフォースモデル、市場魅力度分析、バリューチェーン分析を取り上げています。これらのツールは、業界の構造を明確に把握し、世界レベルでの競合の魅力を評価するのに役立ちます。さらに、これらのツールは、小児成長ホルモン欠乏症の世界市場における各セグメントを包括的に評価することもできます。小児成長ホルモン欠乏症産業の成長と動向は、この研究に全体的なアプローチを提供します。

地域分析：

本セクションでは、北米、欧州、アジア太平洋、ラテンアメリカ、中東・アフリカにおける小児成長ホルモン欠乏症市場の現在および将来の需要を強調する地域展望をカバーします。さらに、本レポートでは、著名な全地域における個々のアプリケーションセグメントの需要・推定・予測に焦点を当てています。

カスタム要件がある場合は、お問い合わせください。当社の調査チームは、お客様のニーズに応じてカスタマイズしたレポートを提供することができます。

目次

第1章 序文

第2章 エグゼクティブサマリー

  • 市場のハイライト
  • 世界市場スナップショット

第3章 小児成長ホルモン欠乏症- 産業分析

  • イントロダクション：市場力学
  • 市場促進要因
  • 市場抑制要因
  • 市場機会
  • 産業動向
  • ポーターのファイブフォース分析
  • 市場魅力度分析

第4章 バリューチェーン分析

  • バリューチェーン分析
  • 原材料分析
    • 原材料リスト
    • 原材料メーカーリスト
    • 主要原材料の価格動向
  • 潜在的バイヤーのリスト
  • マーケティングチャネル
    • ダイレクトマーケティング
    • インダイレクトマーケティング
    • マーケティングチャネル発展動向

第5章 COVID-19発生の影響分析

第6章 世界の小児成長ホルモン欠乏症市場分析：タイプ別

  • タイプ別概要
  • 実績データと予測データ
  • タイプ別分析
  • 先天性GH欠乏症
  • 後天性GH欠乏症
  • 特発性GH欠乏症

第7章 小児成長ホルモン欠乏症の世界市場分析：製品別

  • 製品別概要
  • 実績データと予測データ
  • 製品別分析
  • 粉末
  • 溶剤

第8章 小児成長ホルモン欠乏症の世界市場分析：用途別

  • 概要：用途別
  • 実績データと予測データ
  • 分析：用途別
  • 成長ホルモン欠乏症症
  • 特発性低身長症
  • ターナー症候群
  • 妊娠低年齢症候群
  • プラダーウィリー症候群
  • その他

第9章 世界の小児成長ホルモン欠乏症市場分析：薬剤別

  • 薬剤別概要
  • 実績データと予測データ
  • 薬剤別分析
  • ジェノトロピン
  • ヒューマトロープ
  • ノルディトロピン・フレックスプロ
  • その他

第10章 小児成長ホルモン欠乏症の世界市場分析：流通チャネル別

  • 流通チャネル別概要
  • 実績データと予測データ
  • 流通チャネル別分析
  • 病院薬局
  • 小売薬局
  • オンライン薬局
  • その他

第11章 小児成長ホルモン欠乏症の世界市場分析：地域別

  • 上位企業シェア分析
  • イントロダクション
  • 北米売上分析
    • 概要、実績と予測
    • 北米：セグメント別
    • 北米：国別
    • 米国
    • カナダ
    • メキシコ
  • 欧州売上分析
    • 概要、実績と予測
    • 欧州：セグメント別
    • 欧州：国別
    • 英国
    • フランス
    • ドイツ
    • イタリア
    • ロシア
    • その他欧州
  • アジア太平洋売上分析
    • 概要、実績と予測
    • アジア太平洋：セグメント別
    • アジア太平洋：国別
    • 中国
    • インド
    • 日本
    • 韓国
    • オーストラリア
    • その他アジア太平洋
  • ラテンアメリカ売上分析
    • 概要、実績と予測
    • ラテンアメリカ：セグメント別
    • ラテンアメリカ：国別
    • ブラジル
    • アルゼンチン
    • ペルー
    • チリ
    • その他ラテンアメリカ
  • 中東・アフリカ売上分析
    • 概要、実績と予測
    • 中東・アフリカ：セグメント別
    • 中東・アフリカ：国別
    • サウジアラビア
    • アラブ首長国連邦
    • イスラエル
    • 南アフリカ
    • その他中東とアフリカ

第12章 小児成長ホルモン欠乏症企業の競合情勢

  • 小児成長ホルモン欠乏症市場競争
  • 提携・協力・合意
  • 合併・買収
  • 新製品上市
  • その他の開発

第13章 企業プロファイル

  • 企業シェア分析
  • 市場集中度
  • Novo Nordisk A/S
  • Eli Lily and Company
  • Novartis AG
  • Merck KGaA
  • Pfizer Inc.
  • Ferring B.V
  • Genentech
  • BioParteners GmbH
  • LG Chem Ltd.
  • Ipsen Pharma
図表

LIST OF TABLES

  • Market Snapshot
  • Drivers : Impact Analysis
  • Restraints : Impact Analysis
  • List of Raw Material
  • List of Raw Material Manufactures
  • List of Potential Buyers
  • Analysis by Type (USD MN)
  • Congenital GH Deficiency Market Sales by Geography (USD MN)
  • Acquired GH Deficiency Market Sales by Geography (USD MN)
  • Idiopathic GH Deficiency Market Sales by Geography (USD MN)
  • Analysis Market by Product (USD MN)
  • Powder Market Sales by Geography (USD MN)
  • Solvent Market Sales by Geography (USD MN)
  • Analysis by Application (USD MN)
  • Growth Hormone Deficiency Market Sales by Geography (USD MN)
  • Idiopathic Short Stature Market Sales by Geography (USD MN)
  • Turner Syndrome Market Sales by Geography (USD MN)
  • Small For Gestational Age Market Sales by Geography (USD MN)
  • Prader-Willi Syndrome Market Sales by Geography (USD MN)
  • Others Market Sales by Geography (USD MN)
  • Analysis by Drug (USD MN)
  • Genotropin Market Sales by Geography (USD MN)
  • Humatrope Market Sales by Geography (USD MN)
  • Norditropin FlexPro Market Sales by Geography (USD MN)
  • Others Market Sales by Geography (USD MN)
  • Analysis by Distribution Channel (USD MN)
  • Hospital Pharmacies Market Sales by Geography (USD MN)
  • Retail Pharmacies Market Sales by Geography (USD MN)
  • Online Pharmacies Market Sales by Geography (USD MN)
  • Others Market Sales by Geography (USD MN)
  • Global Pediatric Growth Hormone Deficiency Market Sales by Geography (USD MN)
  • North America Market Analysis (USD MN)
  • United State Market Analysis (USD MN)
  • Canada Market Analysis (USD MN)
  • Mexico Market Analysis (USD MN)
  • Europe Market Analysis (USD MN)
  • Europe Market Estimate by Country (USD MN)
  • United Kingdom Market Analysis (USD MN)
  • France Market Analysis (USD MN)
  • Germany Market Analysis (USD MN)
  • Italy Market Analysis (USD MN)
  • Russia Market Analysis (USD MN)
  • Spain Market Analysis (USD MN)
  • Rest of Europe Market Analysis (USD MN)
  • Asia Pacific Market Analysis (USD MN)
  • China Market Analysis (USD MN)
  • Japan Market Analysis (USD MN)
  • India Market Analysis (USD MN)
  • South Korea Market Analysis (USD MN)
  • Australia Market Analysis (USD MN)
  • Rest of Asia Pacific Market Analysis (USD MN)
  • Latin America Market Analysis (USD MN)
  • Brazil Market Analysis (USD MN)
  • Argentina Market Analysis (USD MN)
  • Peru Market Analysis (USD MN)
  • Chile Market Analysis (USD MN)
  • Rest of Latin America Market Analysis (USD MN)
  • Middle East & Africa Market Analysis (USD MN)
  • Saudi Arabia Market Analysis (USD MN)
  • UAE Market Analysis (USD MN)
  • Israel Market Analysis (USD MN)
  • South Africa Market Analysis (USD MN)
  • Rest of Middle East and Africa Market Analysis (USD MN)
  • Partnership/Collaboration/Agreement
  • Mergers And Acquisition

LIST OF FIGURES

  • Research Scope of Pediatric Growth Hormone Deficiency Report
  • Market Research Process
  • Market Research Methodology
  • Global Pediatric Growth Hormone Deficiency Market Size, by Region (USD MN)
  • Porters Five Forces Analysis
  • Market Attractiveness Analysis by Type
  • Market Attractiveness Analysis by Product
  • Market Attractiveness Analysis by Application
  • Market Attractiveness Analysis by Drug
  • Market Attractiveness Analysis by Distribution Channel
  • Market Attractiveness Analysis by Region
  • Value Chain Analysis
  • Global Market Analysis by Type (USD MN)
  • Congenital GH Deficiency Market Sales by Geography (USD MN)
  • Acquired GH Deficiency Market Sales by Geography (USD MN)
  • Idiopathic GH Deficiency Market Sales by Geography (USD MN)
  • Global Market Analysis by Product (USD MN)
  • Powder Market Sales by Geography (USD MN)
  • Solvent Market Sales by Geography (USD MN)
  • Global Market Analysis by Application (USD MN)
  • Growth Hormone Deficiency Market Sales by Geography (USD MN)
  • Idiopathic Short Stature Market Sales by Geography (USD MN)
  • Turner Syndrome Market Sales by Geography (USD MN)
  • Small For Gestational Age Market Sales by Geography (USD MN)
  • Prader-Willi Syndrome Market Sales by Geography (USD MN)
  • Others Market Sales by Geography (USD MN)
  • Global Market Analysis by Drug (USD MN)
  • Genotropin Market Sales by Geography (USD MN)
  • Humatrope Market Sales by Geography (USD MN)
  • Norditropin FlexPro Market Sales by Geography (USD MN)
  • Others Market Sales by Geography (USD MN)
  • Global Market Analysis by Distribution Channel (USD MN)
  • Hospital Pharmacies Market Sales by Geography (USD MN)
  • Retail Pharmacies Market Sales by Geography (USD MN)
  • Online Pharmacies Market Sales by Geography (USD MN)
  • Others Market Sales by Geography (USD MN)
  • Global Market by Revenue
  • North America Market by Revenue
  • Europe Market by Revenue
  • Asia Pacific Market by Revenue
  • Latin America Market by Revenue
  • Middle East & Africa Market by Revenue
  • Recent Development in Industry
  • Top Company Share Analysis

Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.

目次
Product Code: VMR11219904

Pediatric growth hormone deficiency is an uncommon condition that primarily affects children. Pediatric growth hormones, which are generated by the pituitary gland, are crucial for children's growth. Throughout life, growth hormones play a vital role in metabolic and physiological processes. When the pituitary gland or the hypothalamus is damaged, the quantity of growth hormone generated is decreased, resulting in Pediatric Growth Hormone Deficiency, which results in a slower pace of growth and a reduction in height in the affected child.

MARKET DYNAMICS:

The rising prevalence of pituitary gland tumours, endocrine problems, genetic disorders, and family-related growth hormone deficiency is likely to increase the pediatric growth hormone deficiency market. The progress of medical advancements, more government subsidies, and rising activities by several organizations to raise awareness of the problem are the factors that will drive the pediatric growth hormone deficiency market forward. In addition, the rising number of pediatric diagnostic projects and campaigns will increase the pediatric growth hormone deficiency market. However, the high cost of pediatric growth hormone deficiency injections, side effects related to hormone treatment, and insufficient awareness of growth hormone deficiency are the primary factors predicted to hinder the market growth of pediatric growth hormone deficiency.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of pediatric growth hormone deficiency. The growth and trends of pediatric growth hormone deficiency industry provide a holistic approach to this study.

MARKET SEGMENTATION:

This section of the pediatric growth hormone deficiency market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Type

  • Congenital GH Deficiency
  • Acquired GH Deficiency
  • Idiopathic GH Deficiency

By Product

  • Powder
  • Solvent

By Application

  • Growth Hormone Deficiency
  • Idiopathic Short Stature
  • Turner Syndrome
  • Small For Gestational Age
  • Prader-Willi Syndrome
  • Others

By Drug

  • Genotropin
  • Humatrope
  • Norditropin Flexpro
  • Others

By Distribution Channel

  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
  • Others

REGIONAL ANALYSIS:

This section covers the regional outlook, which accentuates current and future demand for the Pediatric Growth Hormone Deficiency market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the pediatric growth hormone deficiency market include Novo Nordisk A/S, Eli Lily and Company, Novartis AG, Merck KGaA, Pfizer Inc., Ferring B.V, Genentech, BioParteners GmbH, LG Chem Ltd., Ipsen Pharma. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

TABLE OF CONTENTS

1 . PREFACE

  • 1.1. Report Description
    • 1.1.1. Objective
    • 1.1.2. Target Audience
    • 1.1.3. Unique Selling Proposition (USP) & offerings
  • 1.2. Research Scope
  • 1.3. Research Methodology
    • 1.3.1. Market Research Process
    • 1.3.2. Market Research Methodology

2 . EXECUTIVE SUMMARY

  • 2.1. Highlights of Market
  • 2.2. Global Market Snapshot

3 . PEDIATRIC GROWTH HORMONE DEFICIENCY - INDUSTRY ANALYSIS

  • 3.1. Introduction - Market Dynamics
  • 3.2. Market Drivers
  • 3.3. Market Restraints
  • 3.4. Opportunities
  • 3.5. Industry Trends
  • 3.6. Porter's Five Force Analysis
  • 3.7. Market Attractiveness Analysis
    • 3.7.1 Market Attractiveness Analysis By Type
    • 3.7.2 Market Attractiveness Analysis By Product
    • 3.7.3 Market Attractiveness Analysis By Application
    • 3.7.4 Market Attractiveness Analysis By Drug
    • 3.7.5 Market Attractiveness Analysis By Distribution Channel
    • 3.7.6 Market Attractiveness Analysis By Region

4 . VALUE CHAIN ANALYSIS

  • 4.1. Value Chain Analysis
  • 4.2. Raw Material Analysis
    • 4.2.1. List of Raw Materials
    • 4.2.2. Raw Material Manufactures List
    • 4.2.3. Price Trend of Key Raw Materials
  • 4.3. List of Potential Buyers
  • 4.4. Marketing Channel
    • 4.4.1. Direct Marketing
    • 4.4.2. Indirect Marketing
    • 4.4.3. Marketing Channel Development Trend

5 . IMPACT ANALYSIS OF COVID-19 OUTBREAK

6 . GLOBAL PEDIATRIC GROWTH HORMONE DEFICIENCY MARKET ANALYSIS BY TYPE

  • 6.1 Overview by Type
  • 6.2 Historical and Forecast Data
  • 6.3 Analysis by Type
  • 6.4 Congenital GH Deficiency Historic and Forecast Sales by Regions
  • 6.5 Acquired GH Deficiency Historic and Forecast Sales by Regions
  • 6.6 Idiopathic GH Deficiency Historic and Forecast Sales by Regions

7 . GLOBAL PEDIATRIC GROWTH HORMONE DEFICIENCY MARKET ANALYSIS BY PRODUCT

  • 7.1 Overview by Product
  • 7.2 Historical and Forecast Data
  • 7.3 Analysis by Product
  • 7.4 Powder Historic and Forecast Sales by Regions
  • 7.5 Solvent Historic and Forecast Sales by Regions

8 . GLOBAL PEDIATRIC GROWTH HORMONE DEFICIENCY MARKET ANALYSIS BY APPLICATION

  • 8.1 Overview by Application
  • 8.2 Historical and Forecast Data
  • 8.3 Analysis by Application
  • 8.4 Growth Hormone Deficiency Historic and Forecast Sales by Regions
  • 8.5 Idiopathic Short Stature Historic and Forecast Sales by Regions
  • 8.6 Turner Syndrome Historic and Forecast Sales by Regions
  • 8.7 Small For Gestational Age Historic and Forecast Sales by Regions
  • 8.8 Prader-Willi Syndrome Historic and Forecast Sales by Regions
  • 8.9 Others Historic and Forecast Sales by Regions

9 . GLOBAL PEDIATRIC GROWTH HORMONE DEFICIENCY MARKET ANALYSIS BY DRUG

  • 9.1 Overview by Drug
  • 9.2 Historical and Forecast Data
  • 9.3 Analysis by Drug
  • 9.4 Genotropin Historic and Forecast Sales by Regions
  • 9.5 Humatrope Historic and Forecast Sales by Regions
  • 9.6 Norditropin FlexPro Historic and Forecast Sales by Regions
  • 9.7 Others Historic and Forecast Sales by Regions

10 . GLOBAL PEDIATRIC GROWTH HORMONE DEFICIENCY MARKET ANALYSIS BY DISTRIBUTION CHANNEL

  • 10.1 Overview by Distribution Channel
  • 10.2 Historical and Forecast Data
  • 10.3 Analysis by Distribution Channel
  • 10.4 Hospital Pharmacies Historic and Forecast Sales by Regions
  • 10.5 Retail Pharmacies Historic and Forecast Sales by Regions
  • 10.6 Online Pharmacies Historic and Forecast Sales by Regions
  • 10.7 Others Historic and Forecast Sales by Regions

11 . GLOBAL PEDIATRIC GROWTH HORMONE DEFICIENCY MARKET ANALYSIS BY GEOGRAPHY

  • 11.1. Top Company Share Analysis
  • 11.2. Introduction
  • 11.3. North America Sales Analysis
    • 11.3.1. Overview, Historic and Forecast Sales Analysis
    • 11.3.2. North America By Segment Sales Analysis
    • 11.3.3. North America By Country Sales Analysis
    • 11.3.4. United State Sales Analysis
    • 11.3.5. Canada Sales Analysis
    • 11.3.6. Mexico Sales Analysis
  • 11.4. Europe Sales Analysis
    • 11.4.1. Overview, Historic and Forecast Sales Analysis
    • 11.4.2. Europe by Segment Sales Analysis
    • 11.4.3. Europe by Country Sales Analysis
    • 11.4.4. United Kingdom Sales Analysis
    • 11.4.5. France Sales Analysis
    • 11.4.6. Germany Sales Analysis
    • 11.4.7. Italy Sales Analysis
    • 11.4.8. Russia Sales Analysis
    • 11.4.9. Rest Of Europe Sales Analysis
  • 11.5. Asia Pacific Sales Analysis
    • 11.5.1. Overview, Historic and Forecast Sales Analysis
    • 11.5.2. Asia Pacific by Segment Sales Analysis
    • 11.5.3. Asia Pacific by Country Sales Analysis
    • 11.5.4. China Sales Analysis
    • 11.5.5. India Sales Analysis
    • 11.5.6. Japan Sales Analysis
    • 11.5.7. South Korea Sales Analysis
    • 11.5.8. Australia Sales Analysis
    • 11.5.9. Rest Of Asia Pacific Sales Analysis
  • 11.6. Latin America Sales Analysis
    • 11.6.1. Overview, Historic and Forecast Sales Analysis
    • 11.6.2. Latin America by Segment Sales Analysis
    • 11.6.3. Latin America by Country Sales Analysis
    • 11.6.4. Brazil Sales Analysis
    • 11.6.5. Argentina Sales Analysis
    • 11.6.6. Peru Sales Analysis
    • 11.6.7. Chile Sales Analysis
    • 11.6.8. Rest of Latin America Sales Analysis
  • 11.7. Middle East & Africa Sales Analysis
    • 11.7.1. Overview, Historic and Forecast Sales Analysis
    • 11.7.2. Middle East & Africa by Segment Sales Analysis
    • 11.7.3. Middle East & Africa by Country Sales Analysis
    • 11.7.4. Saudi Arabia Sales Analysis
    • 11.7.5. UAE Sales Analysis
    • 11.7.6. Israel Sales Analysis
    • 11.7.7. South Africa Sales Analysis
    • 11.7.8. Rest Of Middle East And Africa Sales Analysis

12 . COMPETITIVE LANDSCAPE OF THE PEDIATRIC GROWTH HORMONE DEFICIENCY COMPANIES

  • 12.1. Pediatric Growth Hormone Deficiency Market Competition
  • 12.2. Partnership/Collaboration/Agreement
  • 12.3. Merger And Acquisitions
  • 12.4. New Product Launch
  • 12.5. Other Developments

13 . COMPANY PROFILES OF PEDIATRIC GROWTH HORMONE DEFICIENCY INDUSTRY

  • 13.1. Company Share Analysis
  • 13.2. Market Concentration Rate
  • 13.3. Novo Nordisk A/S
    • 13.3.1. Company Overview
    • 13.3.2. Company Revenue
    • 13.3.3. Products
    • 13.3.4. Recent Developments
  • 13.4. Eli Lily and Company
    • 13.4.1. Company Overview
    • 13.4.2. Company Revenue
    • 13.4.3. Products
    • 13.4.4. Recent Developments
  • 13.5. Novartis AG
    • 13.5.1. Company Overview
    • 13.5.2. Company Revenue
    • 13.5.3. Products
    • 13.5.4. Recent Developments
  • 13.6. Merck KGaA
    • 13.6.1. Company Overview
    • 13.6.2. Company Revenue
    • 13.6.3. Products
    • 13.6.4. Recent Developments
  • 13.7. Pfizer Inc.
    • 13.7.1. Company Overview
    • 13.7.2. Company Revenue
    • 13.7.3. Products
    • 13.7.4. Recent Developments
  • 13.8. Ferring B.V
    • 13.8.1. Company Overview
    • 13.8.2. Company Revenue
    • 13.8.3. Products
    • 13.8.4. Recent Developments
  • 13.9. Genentech
    • 13.9.1. Company Overview
    • 13.9.2. Company Revenue
    • 13.9.3. Products
    • 13.9.4. Recent Developments
  • 13.10. BioParteners GmbH
    • 13.10.1. Company Overview
    • 13.10.2. Company Revenue
    • 13.10.3. Products
    • 13.10.4. Recent Developments
  • 13.11. LG Chem Ltd.
    • 13.11.1. Company Overview
    • 13.11.2. Company Revenue
    • 13.11.3. Products
    • 13.11.4. Recent Developments
  • 13.12. Ipsen Pharma
    • 13.12.1. Company Overview
    • 13.12.2. Company Revenue
    • 13.12.3. Products
    • 13.12.4. Recent Developments

Note - in company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies